Récepteur Soluble pour facteur de nécrose tumorale I (TNF sRI ) /Fc Chimera humaine,,> 95 % (SDS - PAGE ), recombinant, exprimé en CELLULES NSO, poudre lyophile, testée dans la culture cellulaire

Code: t3439-50ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Analysis Note

The biological activity is measured by its ability to neutralize apoptosis of mouse L-929 cells treated with 0.25 ng/ml recombinant human TNF-α.


en savoir plus

Votre prix
$945.63 50UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Analysis Note

The biological activity is measured by its ability to neutralize apoptosis of mouse L-929 cells treated with 0.25 ng/ml recombinant human TNF-α.

Application

Tumor Necrosis Factor Soluble Receptor I (TNF sRI)/Fc Chimera human may be used to study signaling of apoptosis and NF-κB activation.

Biochem/physiol Actions

Tumor Necrosis Factor Soluble Receptor I (TNF sRI)/Fc Chimera human belongs to TNF family of receptors and has a pivotal role in neutralizing the biological activities of both TNF-α and TNF-β. Soluble tumor necrosis factor receptor along with intrathecal interleukin-1 receptor antagonist shows an anti-allodynic action in rat L5 spinal nerve transection model of neuropathic pain.

Physical form

Lyophilized from a 0.2 µm filtered solution in phosphate buffered saline with 2.5 mg bovine serum albumin.

assay>95% (SDS-PAGE)
biological sourcehuman
formlyophilized powder
Gene Informationhuman ... TNFRSF1B(7133)
impuritiesendotoxin, tested
mol wt48 kDa
packagingpkg of 50 µg
potency0.4-1 ng/mL ED50
Quality Level100
recombinantexpressed in NSO cells
storage conditionavoid repeated freeze/thaw cycles
storage temp.−20°C
technique(s)cell culture | mammalian: suitable
UniProt accession no.P20333
Ce produit répond aux critères suivants: